Tag: LAAO
TCT 2022: Amulet occluder keeps pace with Watchman at three years
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...
FEops Heartguide receives FDA clearance for LAAO planning capabilities
FEops has announced that it received authorisation from the US Food and Drug Administration (FDA...
Study shows LAAO reduces major bleeding and mortality compared with NOACs in high-risk AF patients
Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score...
PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, ma...
Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very encouraging”
Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appendage Occlusion (LAAO...
FEops HEARTguide wins CSI Highlight of the Year Award
FEops has won the CSI Frankfurt 2019’s Highlight of the Year Award for its FEops HEARTguide unde...
